Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Machine Learning Prediction of Treatment Response to Inhaled Corticosteroids in Asthma

Machine Learning Prediction of Treatment Response to Inhaled Corticosteroids in Asthma

Thumbnail Image
Download
Name

jpm-14-00246.pdf

Size

869.53 KB

Format

Adobe PDF

Checksum (MD5)

27df99317c8479d1a5dd34a285896a6d

Download all files submitted through automated deposit
packager-66041bee.zip (683.94 KB)
Author(s)
Ong, Mei-Sing
•
Sordillo, Joanne E.
•
Dahlin, Amber
•
McGeachie, Michael
•
Tantisira, Kelan
•
Wang, Alberta L.
•
Lasky-Su, Jessica
•
Brilliant, Murray
•
Kitchner, Terrie
•
Roden, Dan M.
more
Date Issued
February 25, 2024
Publisher
MDPI AG
Citation
Journal of Personalized Medicine 14 (3): 246 (2024)
Version
Final published version
Abstract
Background: Although inhaled corticosteroids (ICS) are the first-line therapy for patients with persistent asthma, many patients continue to have exacerbations. We developed machine learning models to predict the ICS response in patients with asthma. Methods: The subjects included asthma patients of European ancestry (n = 1371; 448 children; 916 adults). A genome-wide association study was performed to identify the SNPs associated with ICS response. Using the SNPs identified, two machine learning models were developed to predict ICS response: (1) least absolute shrinkage and selection operator (LASSO) regression and (2) random forest. Results: The LASSO regression model achieved an AUC of 0.71 (95% CI 0.67–0.76; sensitivity: 0.57; specificity: 0.75) in an independent test cohort, and the random forest model achieved an AUC of 0.74 (95% CI 0.70–0.78; sensitivity: 0.70; specificity: 0.68). The genes contributing to the prediction of ICS response included those associated with ICS responses in asthma (TPSAB1, FBXL16), asthma symptoms and severity (ABCA7, CNN2, PTRN3, and BSG/CD147), airway remodeling (ELANE, FSTL3), mucin production (GAL3ST), leukotriene synthesis (GPX4), allergic asthma (ZFPM1, SBNO2), and others. Conclusions: An accurate risk prediction of ICS response can be obtained using machine learning methods, with the potential to inform personalized treatment decisions. Further studies are needed to examine if the integration of richer phenotype data could improve risk prediction.
Subjects
Medicine (miscellaneous)
Terms of Use
Creative Commons Attribution
https://creativecommons.org/licenses/by/4.0/
Persistent DSpace Link
https://hdl.handle.net/1721.1/153948
DOI of Published Version
https://doi.org/10.3390/jpm14030246
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.